首页|基于调控AMPK信号通路的中药治疗脑缺血再灌注损伤药理机制研究进展

基于调控AMPK信号通路的中药治疗脑缺血再灌注损伤药理机制研究进展

扫码查看
脑缺血再灌注损伤(cerebral ischemia-reperfusion injury,CIRI)指脑血管缺血后血液再次恢复供应,导致脑组织进一步的损伤和功能障碍。目前,现代医学在CIRI的防治中取得了一定的进展,但仍然面临一些挑战和局限性。因此,寻找有效的干预措施来防治CIRI具有重要的临床价值。腺苷酸活化蛋白激酶(AMPK)及其下游蛋白是治疗CIR1的重要靶点,在细胞能量稳态调节中起着关键作用。中药具有多靶点、多途径和多效应的特点,可以激活AMPK信号通路级联反应,通过调节细胞自噬、氧化应激、炎症反应、细胞凋亡等来治疗CIRI,并取得一定成果。故文章总结了 AMPK相关信号通路的结构与机制,详述其与CIRI的关系,并对中医药调控AMPK信号通路防治CIRI的研究现状进行系统性总结,以期为CIRI的中医防治及新药研发提供新的思路。
Research progress on the AMPK signaling pathway-based pharmacological mechanism of traditional Chinese medicine in the treatment of cerebral ischemia-reperfusion injury
Cerebral ischemia-reperfusion injury(CIR1)refers to the recovery of blood supply after cerebral ischemia,which leads to further damage and the dysfunction of brain tissue.Modern medicine has made some progress in the prevention and treatment of CIRI,but it still faces some challenges and limitations.Therefore,it is of great clinical value to find effective interventions to prevent and treat CIRI.AMP-activated protein kinase(AMPK)and its downstream proteins are important targets for the treatment of CIRI and play key roles in the regulation of cellular energy homeostasis.Traditional Chinese medicine for CIRI has multi-target and multi-pathway activities and multiple effects.It can activate a cascade of reactions in the AMPK signaling pathway and can be used to treat CIRI by regulating autophagy,oxidative stress,inflammatory response,and apoptosis,and has achieved certain result.Therefore,this paper summarizes the structure and mechanisms of the AMPK-related signaling pathway,elaborates on its relationship with CIRI,and systematically summarizes the research status of traditional Chinese medicine's ability to regulate the AMPK signaling pathway in the prevention and treatment of CIRI.This paper aims to provide new ideas for the prevention and treatment of CIRI using traditional Chinese medicine and the development of new drugs.

traditional Chinese medicineAMPK signaling pathwaycerebral ischemia-reperfusion injuryresearch progress

贺晨菲、马驰远、冉春龙、程豪格、张数、王森雨、宇翰林、刘向哲

展开 >

河南中医药大学第一附属医院脑病中心,郑州 450000

河南中医药大学第一临床医学院,郑州 450046

中药 AMPK信号通路 脑缺血再灌注损伤 研究进展

河南省科技攻关项目河南省中医药传承与创新人才工程(仲景工程)中医药学科领军人才项目河南省中医药科学研究专项课题

242102311277豫卫中医函[2021]8号2023ZXZX1077

2024

中国比较医学杂志
中国实验动物学会,中国医学科学院医学实验动物研究所

中国比较医学杂志

CSTPCD北大核心
影响因子:0.473
ISSN:1671-7856
年,卷(期):2024.34(9)